|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net (loss) income from operating activities to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Allowance for doubtful accounts | |||||
| Provision for credit losses | |||||
| Inventory write-down | |||||
| Depreciation and amortization | |||||
| Impairment charges | |||||
| (Gain) loss on disposal of property, plant and equipment | |||||
| Goodwill impairment charges | |||||
| Intangible asset impairment charges | |||||
| Gain on disposal of intangible assets | |||||
| Gain on sale of business interest | |||||
| Loss (gain) on sale of equity investment | |||||
| Equity in loss of equity method investees, net of tax | |||||
| Government grant income | |||||
| Change in deferred tax provision | |||||
| Change in foreign exchange contracts | |||||
| Foreign currency transactions | |||||
| Change in contingent consideration obligation | |||||
| Amortization of debt discount | |||||
| Accretion of note receivable | |||||
| Changes in: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Accrued expenses and other current liabilities | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Proceeds from sale of business interest | |||||
| Proceeds from partnership transaction | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Net proceeds from sale of marketable securities | |||||
| Proceeds from sale of assets held for sale | |||||
| Acquisition of germplasm | |||||
| Capital contributions to partnerships | |||||
| Net proceeds from sale of equity investment | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Borrowings and repayments on lines of credit, net | |||||
| Borrowings of long-term debt | |||||
| Capital contribution from minority shareholder of subsidiary | |||||
| Repayments of long-term debt | |||||
| Payments of debt issuance costs | |||||
| Cash paid related to stock issuance costs | |||||
| Net proceeds from sale of common stock | |||||
| Net proceeds from sale of Series B convertible preferred stock | |||||
| Issuance of common stock for cash upon exercise of stock options | |||||
| Taxes paid related to net share settlements of stock-based compensation awards | |||||
| Net cash (used in) provided by financing activities | |||||
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | |||||
| NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, beginning of the period | |||||
| CASH AND CASH EQUIVALENTS, end of period | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...